CD38 and Miyoshi myopathy: Additionally, Poles et al. showed that BCMA-CARs or affinity-optimized CD38-CARs with CIK cells not only spared normal hematopoietic cells but also exhibited a Th1-like cytokine profile, further supporting their therapeutic utility in MM [314].